David A. Siegel Second Sight Medical Products Inc Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.63 - $3.41 $22,494 - $47,058
-13,800 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$3.11 - $4.75 $42,918 - $65,550
13,800 New
13,800 $44,000

About SECOND SIGHT MEDICAL PRODUCTS INC

EYES Quotes by TradingView
  • Ticker EYES
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 13,136,400
  • Market Cap $54.4M
  • Description
  • Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulati...
More about EYES
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email